The cost of pharmacovigilance: a time and motion study of an adverse drug reaction program
Gina B McLachlan1, Claire Keith1, Catherine Wood1
1Medicines Information, Pharmacy Department, Austin Health, Heidelberg, VIC, Australia.
Objectives:
Adverse medication events are associated with a significant number of hospital admissions, and the appropriate recording of these events plays a vital role in medication safety. We set out to analyse the time and extrapolated cost in reporting adverse drug reactions (ADRs).
Methods:
A time and motion study of the tasks involved in reviewing, assessing, reporting and communicating ADRs was done over a period of 2 months.
Key Findings:
We found a median of 69 min was needed in background work per ADR report.
Conclusion:
The commitment involved in the support of this program is considerable and will encourage further refinement to streamline the process.
Related Concept Videos
01:19Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:14Time Course of Drug Effect
01:20Measurement of Bioavailability: Pharmacodynamic Methods
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
01:29Therapeutic Drug Monitoring: Affecting Factors
01:15Drug Concentration Versus Time Correlation
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...